Date of Conferral
6-5-2025
Date of Award
June 2025
Degree
Doctor of Psychology (Psy.D.)
School
Psychology
Advisor
Andrea Goldstein
Abstract
Behavioral health professionals are concerned with the opioid epidemic in the United States, as opioid use results in needless overdose deaths annually. Relapse prevention is the theory that grounded this study, and naltrexone or extended-release naltrexone (XR-NTX) was used to measure effectiveness for 50 forensic, rural, and urban individuals with opioid use disorder (OUD) to prevent relapse. Furthermore, this study used a chi square test of independence, nonparametric test with a Cramer’s V, and Fisher’s exact. While outcomes revealed no significant differences between rural and urban groups, significant evidence was observed when medication outcomes and medication extent were evaluated, Pearson chi square p < .001, Cramer’s V = 1.0, p < .001, and Fisher’s exact = 56.094, p < .001. This study provided a nucleus for positive social change by helping to save, change, and improve lives and to offer hope to a population that often feels that they have no hope. Going forward, recommendations for the behavioral health field should include further study of forensic, rural, and urban populations with OUD, as well as evaluation of the effectiveness of naltrexone and XR-NTX
Recommended Citation
Mulford, Francis Anthony, "The Effectiveness of Vivitrol and Naltrexone for Rural and Urban Participants Post-incarceration or Under Supervision" (2025). Walden Dissertations and Doctoral Studies. 17915.
https://scholarworks.waldenu.edu/dissertations/17915
